Miaoli, Taiwan

Wei Chen



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Wei Chen: Pioneering Antiviral Solutions from Cyanobacterial Extracts

Introduction: Wei Chen, an accomplished inventor based in Miaoli, Taiwan, is making significant strides in the realm of biotechnology. With a focus on antiviral applications, his innovative work has garnered attention in the scientific community. He is affiliated with Far East Bio-tec Co., Ltd., where he collaborates with talented colleagues such as Chuang-Chun Chiuh and Yi-Hsiang Chen.

Latest Patents: Wei Chen holds a notable patent for an antiviral extract derived from Arthrospira maxima. This groundbreaking invention presents various cyanobacterial extracts that exhibit antiviral activity against a wide range of viruses, including enterovirus (EV), respiratory syncytial virus (RSV), human herpesvirus (HHV), Ebola virus, and porcine viruses such as porcine epidemic diarrhea virus (PEDV) and porcine reproductive and respiratory syndrome virus (PRRSV). The patent not only details the preparation process of these extracts but also explores their practical applications in combating viral infections.

Career Highlights: Throughout his career, Wei Chen has demonstrated a deep commitment to advancing biotechnology through innovative research and development. His contributions to the field reflect a keen understanding of the complexities of viral diseases and the potential of natural extracts in therapeutic applications. With one patent to his name, Chen's work stands poised to make impactful contributions to public health and disease management.

Collaborations: Collaboration has been a hallmark of Wei Chen's career. Working alongside esteemed colleagues such as Chuang-Chun Chiuh and Yi-Hsiang Chen at Far East Bio-tec Co., Ltd., he has been able to synergize his expertise and innovate effectively. These teamwork efforts enhance the research process, leading to more robust findings and applications for antiviral treatments.

Conclusion: Wei Chen is an inventive force within the biotechnology sector, with his patent for the antiviral Arthrospira maxima extract showcasing his commitment to developing viable solutions for combating viral infections. His career, marked by collaboration and innovation, reflects a dedication to improving health outcomes through scientific advancements. As his research progresses, the potential impact of his work on global health continues to expand.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…